AVAGLIANO, CARMEN
 Distribuzione geografica
Continente #
NA - Nord America 699
EU - Europa 460
AS - Asia 215
AF - Africa 11
SA - Sud America 5
OC - Oceania 2
Totale 1.392
Nazione #
US - Stati Uniti d'America 679
IT - Italia 269
SG - Singapore 103
CN - Cina 68
NL - Olanda 56
IE - Irlanda 36
VN - Vietnam 26
CA - Canada 20
FR - Francia 18
DE - Germania 17
FI - Finlandia 17
GB - Regno Unito 14
IN - India 9
CI - Costa d'Avorio 8
BG - Bulgaria 7
TR - Turchia 7
UA - Ucraina 6
CZ - Repubblica Ceca 5
ES - Italia 4
EG - Egitto 3
AR - Argentina 2
AU - Australia 2
BR - Brasile 2
EE - Estonia 2
RO - Romania 2
AT - Austria 1
BE - Belgio 1
CL - Cile 1
HU - Ungheria 1
IL - Israele 1
MK - Macedonia 1
NO - Norvegia 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 1.392
Città #
Chandler 160
Singapore 83
Naples 61
Ashburn 55
Amsterdam 50
Napoli 42
Millbury 32
Dearborn 29
Dong Ket 26
Des Moines 23
Santa Clara 23
Princeton 19
Beijing 16
Boston 15
Ottawa 12
Lawrence 10
Nanjing 9
Nanchang 8
Wilmington 8
Cagliari 7
Sofia 7
Milan 6
Pune 6
Shenyang 6
Brno 5
Changsha 5
Dublin 5
London 5
Afragola 4
Bacoli 4
Hebei 4
Houston 4
Istanbul 4
Los Angeles 4
Menlo Park 4
Norwalk 4
Redwood City 4
Seattle 4
Córdoba 3
Frankfurt Am Main 3
Jacksonville 3
Parma 3
Piovene Rocchette 3
Tianjin 3
Crispano 2
Fairfield 2
Jiaxing 2
Marcianise 2
Montréal 2
Mugnano di Napoli 2
Munich 2
Pomigliano d'Arco 2
Portici 2
San Giórgio Di Nogaro 2
Sapri 2
Scisciano 2
Tallinn 2
Tito 2
Woodbridge 2
Wuhan 2
Zhengzhou 2
Çanakkale 2
Ann Arbor 1
Bangkok 1
Boardman 1
Bologna 1
Buenos Aires 1
Cairo 1
Caivano 1
Cancellara 1
Caserta 1
Cava De' Tirreni 1
Cavenago Di Brianza 1
Chatsworth 1
Dallas 1
Dalmine 1
Easton 1
Edinburgh 1
Fairfax 1
Federal 1
Formia 1
Fort Worth 1
Fremantle 1
Fremont 1
Fuzhou 1
Gesualdo 1
Giugliano In Campania 1
Granada 1
Groningen 1
Grumo Nevano 1
Guangzhou 1
Heidelberg 1
Hunedoara 1
Indiana 1
Jinan 1
Maasmechelen 1
Manchester 1
Mountain View 1
Mumbai 1
New York 1
Totale 865
Nome #
Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases 95
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity 88
Ketogal: A Derivative Ketorolac Molecule with Minor Ulcerogenic and Renal Toxicity 73
Pharmacokinetic characteristics and pharmacological profile of polyethylenglicole derivatives of palmitoylethanolamide (PEA) 72
Phenylalanine Butyramide Is a New Cosmetic Ingredient with Soothing and Anti-Reddening Potential 67
Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice 60
Central administration of oxytocin reduces hyperalgesia in mice: Implication for cannabinoid and opioid systems. 49
Uncovering the role of the lipid receptor PPAR-alpha on higher brain functions 48
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. 47
Role of sodium butyrate and of its new prodrug N-(1-carbamoyl-2-phenyl-ethyl) butyramide (FBA) in gastrointestinal transit, castor oil-induced diarrhoea, and croton oil-induced intestinal inflammation 47
Nutraceuticals: An integrative approach to starve Parkinson’s disease 47
Analgesic properties of N-(1-carbomyl 2-phenyl-ethyl)butyramide a new synthetic butyrate pro-drug in a model of acute and visceral pain 46
Fatty acid acyl ethanolamines and PPAR-alpha in neurodegenerative and neurological diseases. Cellular models of neurodegeneration: preliminary data 46
Improvement of Topical Palmitoylethanolamide Anti-Inflammatory Activity by Pegylated Prodrugs 46
Characterization of New TRPM8 Modulators in Pain Perception 45
Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice 44
Biological Profile of Two Gentiana lutea L. Metabolites Using Computational Approaches and In Vitro Tests 41
Galactosyl prodrug of palmitoylethanolamide: Synthesis, stability, cell permeation and cytoprotective activity 40
Peroxisome proliferator-activated receptor (PPAR)-alpha activation produces antidepressant-like effects in mice 40
Antinociceptive effect of two novel transient receptor potential melastatin 8 antagonists in acute and chronic pain models in rat 40
Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease. 38
Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy 37
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2′-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 36
Potential Clinical Applications of the Postbiotic Butyrate in Human Skin Diseases 35
Dual-Hit Model of Parkinson's Disease: Impact of Dysbiosis on 6-Hydroxydopamine-Insulted Mice-Neuroprotective and Anti-Inflammatory Effects of Butyrate. [*Avagliano C. and Coretti L. co-first authors] 31
The Protective Role of Butyrate against Obesity and Obesity-Related Diseases 30
Modulation of Pain Sensitivity by Chronic Consumption of Highly Palatable Food Followed by Abstinence: Emerging Role of Fatty Acid Amide Hydrolase 29
The Beneficial Effects of Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain and Associated Mood Disorders Induced by Paclitaxel in Mice 28
Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence 28
Response to comment by Juan Segura-Aguilar: New preclinical model are required to discover neuroprotective compound in Parkinson's disease 27
Effects of Chronic Oral Probiotic Treatment in Paclitaxel-Induced Neuropathic Pain 25
Phaseolus vulgaris L. Extract: Alpha-amylase inhibition against metabolic syndrome in mice 25
Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction 23
Phaseolus vulgaris extract ameliorates high-fat diet-induced colonic barrier dysfunction and inflammation in mice by regulating peroxisome proliferator-activated receptor expression and butyrate levels 15
Totale 1.488
Categoria #
all - tutte 6.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.095


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202096 0 0 0 0 15 32 9 8 4 10 9 9
2020/2021138 2 1 2 5 13 12 14 6 35 6 9 33
2021/2022261 2 1 2 22 25 3 7 8 33 23 59 76
2022/2023414 30 16 18 42 52 43 6 56 56 58 31 6
2023/2024207 11 30 33 15 10 18 14 30 1 8 21 16
2024/2025151 62 37 4 21 27 0 0 0 0 0 0 0
Totale 1.488